PVLA
The table below shows Palvella Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $57.98M | $83.60M | $17.40M | $38.63M | $117.76M | $70.44M |
| Short-term investments | - | - | $8.97M | $20.53M | - | $0.00 |
| Receivables | $0.00 | $358.00K | $572.00K | $5.81M | $3.31M | $1.71M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $58.99M |
| $88.23M |
| $38.68M |
| $73.42M |
| $127.63M |
| $75.72M |
| Property, plant & equipment | - | - | $0.00 | $16.99M | $19.12M | $22.05M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $59.56M | $88.23M | $38.68M | $95.49M | $153.56M | $105.01M |
| Accounts payable | $4.59M | $4.59M | $3.37M | $4.15M | $8.61M | $1.79M |
| Total current liabilities | $11.34M | $12.04M | $11.92M | $36.58M | $50.56M | $22.14M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $31.58M | $25.63M | $11.92M | $67.56M | $102.81M | $73.98M |
| Retained earnings | -$135.45M | -$93.73M | -$314.96M | -$290.42M | -$257.14M | -$211.41M |
| Total equity | $27.98M | $62.61M | $26.76M | $27.93M | $50.76M | $31.03M |